High Growth Tech Stocks in Europe with Promising Potential
Name
Revenue Growth
Earnings Growth
Growth Rating
Intellego Technologies
30.26%
44.76%
★★★★★★
KebNi
20.56%
94.46%
★★★★★★
innoscripta
24.76%
26.32%
★★★★★★
Pharma Mar
29.61%
44.92%
★★★★★★
Bonesupport Holding
24.39%
57.52%
★★★★★★
Napatech
61.09%
102.68%
★★★★★★
Skolon
31.51%
99.52%
★★★★★★
Xbrane Biopharma
24.95%
56.77%
★★★★★★
Rubean
45.56%
108.82%
★★★★★★
Elliptic Laboratories
36.33%
78.99%
★★★★★★
Click here to see the full list of 231 stocks from our European High Growth Tech and AI Stocks screener.
Let's dive into some prime choices out of from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Grifols, S.A. is a plasma therapeutic company with operations in Spain, the United States, Canada, and internationally, and it has a market cap of approximately €7.04 billion.
Operations: Grifols generates revenue primarily from its Biopharma segment, contributing approximately €6.27 billion, followed by the Diagnostic and Bio Supplies segments at €656.74 million and €221.21 million, respectively.
Grifols has demonstrated a robust trajectory in the biotech sector, with an anticipated earnings growth of 27% annually, outpacing the Spanish market's average. This growth is supported by a revenue increase forecast at 5.8% per year, also above the national average of 4.6%. Despite challenges like a large one-off loss of €143 million affecting its recent financial results, Grifols continues to innovate and expand its influence in biotechnology. Recent strategic moves include leadership changes and amendments to company bylaws aimed at enhancing governance and compliance with current laws, positioning Grifols for sustained future growth within high-tech biotech spheres.
Get an in-depth perspective on Grifols' performance by reading our health report here.
Review our historical performance report to gain insights into Grifols''s past performance.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Indra Sistemas, S.A. is a global technology and consulting company specializing in aerospace, defense, and mobility sectors, with a market capitalization of approximately €6.65 billion.
Operations: Indra Sistemas generates revenue primarily from its Minsait (IT) segment, contributing €3.01 billion, followed by its Defense and Air Traffic segments at €1.07 billion and €470.38 million, respectively. The Mobility segment adds €362.45 million to the company's revenue stream.
Indra Sistemas, a Spanish technology and defense firm, recently showcased its commitment to innovation at the FPGA Conference in Germany, highlighting its strategic role in aerospace and defense markets. The company's recent alliance with AXISCADES to produce advanced aerospace solutions underscores its global strategy and operational depth. Financially, Indra has outperformed the broader IT sector with a 23.4% earnings growth this past year, significantly surpassing the industry's -0.6%. This growth trajectory is supported by an aggressive R&D investment strategy that aligns with expected revenue increases of 7.5% annually and forecasted earnings growth of 13.7% per year, reflecting robust financial health and market confidence in its future prospects.
Click here to discover the nuances of Indra Sistemas with our detailed analytical health report.
Examine Indra Sistemas' past performance report to understand how it has performed in the past.
Simply Wall St Growth Rating: ★★★★★☆
Overview: argenx SE is a commercial-stage biopharma company focused on developing therapies for autoimmune diseases across several international markets, with a market cap of €29.71 billion.
Operations: argenx SE generates revenue primarily from its biotechnology segment, amounting to $2.64 billion. The company focuses on developing therapies for autoimmune diseases in multiple international markets, including the United States and Japan.
argenx, a trailblazer in immunology, recently inked a pivotal deal with Unnatural Products Inc. to develop oral macrocyclic peptide drugs, showcasing its innovative edge by targeting previously undruggable disease markers. This collaboration not only underscores argenx's commitment to expanding its therapeutic portfolio but also leverages UNP's cutting-edge AI-driven platform for drug discovery, potentially revolutionizing treatment paradigms across various diseases. Financially robust, argenx reported a significant revenue jump to $807.37 million in Q1 2025 from $412.51 million the previous year and flipped its net position from a loss of $61.6 million to a profit of $169.47 million, reflecting strong operational execution and market confidence in its strategic direction.
Take a closer look at argenx's potential here in our health report.
Assess argenx's past performance with our detailed historical performance reports.
Discover the full array of 231 European High Growth Tech and AI Stocks right here.
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:GRF BME:IDR and ENXTBR:ARGX.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
Paul Pogba hammers Manchester United over Marcus Rashford exit call
Barcelona are looking to imminently confirm the arrival of Marcus Rashford after clinching a loan agreement with Manchester United. As the saga continues to roll on in the UK and Spain the latest update indicates Barcelona have agreed a deal to sign Rashford from United, with the 27-year-old attacker landing in Catalonia as part of a season-long loan with an option to buy, believed to be in the region of €30-35m. Barcelona increased their focus on bringing in Rashford in the last week following a mixed summer in the the transfer market. Rashford will act as cover for Raphinha on the left of Barcelona's attack, after the club had previously chased deals for Nico Williams and Luis Diaz. He is expected to fly into Catalonia and complete his medical before signing all appropriate documents over the coming days to seal the finalities of the switch. Hansi Flick is hopeful he can include Rashford in his squad for their pre-season tour of Japan and South Korea but that remains uncertain at this stage. Image via Alex Livesey / Getty Images Despite their ongoing financial issues, Barcelona are willing to bankroll a move for Rashford, and reports from The Times claim they will cover his full £325,000 a week wages as part of the loan. A move away from Manchester has looked certain since the start of the summer but former United teammate Paul Pogba has waded in to support Rashford. Pogba has recently returned to football following a ban, joining AS Monaco, and the Frenchman believes the Red Devils treatment of Rashford has been unfair throughout. 'This is a crazy situation. But, I'm happy for him because they took away his number in Manchester,' he said. 'Manchester United are losing a great player. Unlucky for them. 'It's great for Barcelona to be honest. I'm not even talking about United, because they've bought a few new players and the new manager wants to do his thing I guess. '
Bloomberg
an hour ago
- Bloomberg
UK Second-Hand Shopping to Hit £4.8 Billion This Year, CEBR Says
Two-thirds of British consumers bought second-hand goods online last year, research shows, a figure expected to grow as shoppers rein in spending and as so-called 'pre-loved' items become more available. Purchases of used goods on the internet will reach £4.8 billion ($6.4 billion) in the UK this year, up from £4.3 billion in 2024, according to a report from the Centre for Economics and Business Research commissioned by Inc.
Yahoo
an hour ago
- Yahoo
Own AMPL stock? This Is the 1 Thing to Watch Now.
Key Points The cloud software company recently launched new AI agents. Earlier this month, the company acquired Kraftful, an AI startup. At a market cap of $1.5 billion, Amplitude still has considerable upside potential. 10 stocks we like better than Amplitude › Amplitude (NASDAQ: AMPL) caught a lot of attention from investors when it debuted in 2021. At the time, the cloud software company, which is focused on product analytics, was growing rapidly and tech stocks were still booming from the pandemic-driven tailwinds. However, Amplitude tumbled in the tech crash in 2022. The stock plunged and growth has slowed as many of its customers realized that they overestimated their need for its services, much like they did with most other software products, as the tech industry lost some of its primacy in the economic reopening following the pandemic lockdowns. The company was forced to lay off employees and retrench, and after some acquisitions and with the headwinds from the customer spend rationalization finally rolling off, Amplitude looks as strong as it's been in a long time. In fact, the stock has surged of late, up 56% over the last year as investors have responded to the company's momentum in its product lineup. However, there's one thing investors should be watching now. What can Amplitude do with AI? Amplitude, which still trades in a small-cap range at a market cap of less than $2 billion, is arguably as well-positioned as any company of its size to capitalize on AI technology. The company helps businesses discover and understand how customers use their digital products, like websites, apps, and other devices so they can learn what's working and make improvements. In the digital era, that's a valuable tool, and it could be greatly enhanced with artificial intelligence, which has the power to automate insights that now require a human to glean through data analysis. The company introduced its new Amplitude AI agents in June, which will do things like pull dashboards, run queries, test hypotheses, and determine which leads are the most promising. Among the specific AI agent templates are website conversion agents, onboarding agents, feature adoption agents, and monetization agents, which help improve the nuts-and-bolts points of engagement that most businesses are trying to accomplish online. Amplitude followed that up in July with its acquisition of Kraftful, an AI-native Voice of the Customer (VoC) start-up. Amplitude will capitalize on Kraftful's proprietary large language model (LLM), which can process massive amounts of user feedback data. The acquisition will help Amplitude further lock the capabilities in the data its software is uncovering, making its product suite even more valuable for customers. What's next for Amplitude In its first quarter, Amplitude reported 12% annual recurring revenue growth and 10% overall revenue growth, an improvement from recent years. The company has seen a jump in remaining performance obligations as well, which rose 30% to $325.9 million, showing that its customers are committing to longer contracts. That's a good sign that growth momentum is returning after years of elevated churn coming off the pandemic. Amplitude has a large base of more than 4,000 customers, ranging across industries from tech to consumer to industrials, and that includes 27% of the Fortune 100, showing it's landing large companies as well. Seeing a bump from the new AI agents could take time, but the new products will almost certainly help accelerate Amplitude's growth over the long term. The company was recently rated No. 1 in product analytics by G2, a research firm, and it has gained market share from larger competitors like Google Analytics and Adobe Analytics, which are more focused on marketing analytics rather than product analytics. As a leader in an emerging niche in software at a market cap of just $1.5 billion, Amplitude has a lot of upside potential. If its new AI agents gain traction, the stock could soar. Should you buy stock in Amplitude right now? Before you buy stock in Amplitude, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Amplitude wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Adobe. The Motley Fool has a disclosure policy. Own AMPL stock? This Is the 1 Thing to Watch Now. was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
